KROS Keros Therapeutics - keith regnante resigns as CFO effective August 3, 2026 - SEC filing - Appoints annita tanini interim Principal fin
KROS Keros Therapeutics - keith regnante resigns as CFO effective August 3, 2026 - SEC filing - Appoints annita tanini interim Principal financial officer effective August 4, 2026 - SEC filing
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.